BHC — Bausch Health Companies Inc.

—
NYSE · Health Care · Pharmaceuticals · CIK 885590 ·
Last close
$8.47
Market Cap
$3.17B
52W High
$9.04
52W Low
$4.33
ADV30
3,888,584
Next earnings
2026-10-28

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGross profitOp incomeNet incomeAssetsCashLiabilities
Sep 2026 2,941,000,000 2,206,000,000 1,004,000,000 436,000,000 25,484,000,000 2,485,000,000 25,825,000,000
Jun 2026 2,852,000,000 2,080,000,000 775,000,000 258,000,000 24,794,000,000 1,825,000,000 25,596,000,000
Mar 2026 2,524,000,000 1,786,000,000 521,000,000 -1,423,000,000 24,498,000,000 1,299,000,000 25,580,000,000
Dec 2025 2,796,000,000 1,998,000,000 829,000,000 -112,000,000 26,366,000,000 1,309,000,000 25,989,000,000

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$2,209,000,000
Investing CF
$-597,000,000
Financing CF
$-464,000,000
CapEx
$-382,000,000
Dividends Paid
$0
Buybacks
—
EPS Diluted TTM
$-2.29
As of
2026-11-01

Balance + Analyst (yfinance extras)

Retained Earnings
$-10,396,000,000
Inventory
$1,591,000,000
Receivables
$2,533,000,000
ST Investments
—
EBIT TTM
$1,240,000,000
Pretax Income TTM
$-353,000,000
Interest Exp TTM
$1,593,000,000
Analysts
5

Yahoo Snapshot (yfinance, live)

Total Revenue
$11,112,999,936
EBITDA
$4,171,000,064
Free Cash Flow
$1,640,499,968
Enterprise Value
$22,285,987,840
Total Cash
$2,484,999,936
Total Debt
$20,714,999,808
Shares Out
374,266,716
Trailing EPS
$-2.26
Book Value
$-3.55
ROE
-11040.0%
ROA
7.2%
Div Yield
0.00%

Annual Trend (SEC EDGAR, last 4y)

Revenues vs Net Income (last 4y)

FY endRevenuesOp incomeNet incomeAssetsLiabilitiesEquityOp cash flow
Dec 2025 10,266,000,000 2,185,000,000 157,000,000 26,366,000,000 25,989,000,000 -554,000,000 1,400,000,000
Dec 2024 9,625,000,000 1,854,000,000 -46,000,000 26,523,000,000 26,845,000,000 -1,279,000,000 1,597,000,000
Dec 2023 8,757,000,000 1,600,000,000 -592,000,000 27,350,000,000 27,432,000,000 -1,022,000,000 1,032,000,000
Dec 2022 8,124,000,000 1,391,000,000 -225,000,000 25,686,000,000 25,426,000,000 -692,000,000 -728,000,000

TTM Snapshot

Revenues TTM
$10,853,000,000
NetIncome TTM
$-1,098,000,000
OpCashFlow TTM
—
Assets (Latest)
$24,794,000,000
Forward EPS
$4.34

Max Pain — expiry 2027-01-15

max pain strike: $6.00 · spot: $8.73 · call oi: 29,801 · put oi: 10,906
Expected Move to 2027-01-15: ±$1.50 (17.18%) — implied range $7.23 – $10.23 · ATM straddle on $9.00 strike

Peers — same industry

TickerNameMarket CapLastDaily %
ACAD ACADIA PHARMACEUTICALS INC $3.17B $18.32 —
LEGN Legend Biotech Corp $3.13B $16.11 —
BGM BGM Group Ltd. $3.09B $8.13 —
XERS Xeris Biopharma Holdings, Inc. $3.07B $16.80 —
TLX Telix Pharmaceuticals Ltd $3.01B $8.85 —

News headlines (Yahoo Finance, 1h cache)

Bausch Health's Gastroenterology Business, Salix, to Present New Data on Cirrhosis Trends and Severe Alcohol-Associated Hepatitis at The Liver Meeting® 2026
2026-11-06 12:00 · Yahoo
BHC Q3 Earnings Call Highlights Raised Outlook, Xifaxan Risks
2026-11-04 14:00 · Yahoo
Up 55% in October: Is Bausch Health’s turnaround just getting started?
2026-10-30 15:02 · Yahoo
BHC Q3 Earnings Beat on Salix Growth, Stock Gains 9% as Outlook Rises
2026-10-29 13:43 · Yahoo
Bausch Health Companies Inc. Q3 2026 Earnings Call Summary
2026-10-29 12:30 · Yahoo
Bausch: Q3 Earnings Snapshot
2026-10-28 21:18 · Yahoo
Bausch Health soars on earnings beat and raised outlook
2026-10-28 21:05 · Yahoo
Bausch Health Announces Full Redemption of 8.500% Senior Notes Due 2027
2026-10-28 20:07 · Yahoo
Bausch Health Announces US$50 Million Share Repurchase Program
2026-10-28 20:06 · Yahoo
Is Bausch Health (BHC) Stock Outpacing Its Medical Peers This Year?
2026-11-03 13:40 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.